4,206
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease: a systematic review and meta-analysis

, , , , , , ORCID Icon & show all
Article: 2169618 | Received 14 Nov 2022, Accepted 12 Jan 2023, Published online: 27 Jan 2023

References

  • Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305.
  • Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2018 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2019;73(3 Suppl. 1):A7–A8.
  • Ku E, McCulloch CE, Ahearn P, et al. Trends in cardiovascular mortality among a cohort of children and young adults starting dialysis in 1995 to 2015. JAMA Netw Open. 2020;3(9):e2016197.
  • de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302(16):1782–1789.
  • Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093–2109.
  • Wong G, Howard K, Chapman JR, et al. Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLOS One. 2012;7(1):e29591.
  • Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–1730.
  • Wyld M, Morton RL, Hayen A, et al. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med. 2012;9(9):e1001307.
  • Meier-Kriesche HU, Port FK, Ojo AO, et al. Effect of waiting time on renal transplant outcome. Kidney Int. 2000;58(3):1311–1317.
  • Haller MC, Kainz A, Baer H, et al. Dialysis vintage and outcomes after kidney transplantation: a retrospective cohort study. Clin J Am Soc Nephrol. 2017;12(1):122–130.
  • Abramowicz D, Hazzan M, Maggiore U, et al. Does pre-emptive transplantation versus post start of dialysis transplantation with a kidney from a living donor improve outcomes after transplantation? A systematic literature review and position statement by the Descartes Working Group and ERBP. Nephrol Dial Transplant. 2016;31(5):691–697.
  • Fishbane S, Nair V. Opportunities for increasing the rate of preemptive kidney transplantation. Clin J Am Soc Nephrol. 2018;13(8):1280–1282.
  • Kramer A, Pippias M, Noordzij M, et al. The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary. Clin Kidney J. 2019;12(5):702–720.
  • Global Observatory on Donation and Transplantation. International report on organ donation and transplantation activities executive summary; 2020; [cited 2022 Jan 19]. Available from: http://www.transplant-observatory.org/2020-international-activities-report/
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
  • Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012.
  • Nakamura T, Ushigome H, Nakao T, et al. Advantages and disadvantages of pre-emptive kidney transplantation: results from a single transplantation center. Transplant Proc. 2015;47:626–629.
  • GRADEpro GDT: GRADEpro Guideline Development Tool [Software] (developed by Evidence Prime, Inc.). McMaster University; 2020; [cited 2022 Jan 9]. Available from: https://www.gradepro.org/
  • Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926.
  • Schunemann HJ, Cuello C, Akl EA, et al. GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence. J Clin Epidemiol. 2019;111:105–114.
  • Mitsui Y, Araki M, Maruyama Y, et al. Quality of life and mental satisfaction improve slowly in preemptive kidney transplantation compared with nonpreemptive kidney transplantation. Transplant Proc. 2020;52(3):740–747.
  • Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, et al. Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant. 2005;20(1):167–175.
  • Coll B, Betriu A, Martínez-Alonso M, et al. Large artery calcification on dialysis patients is located in the intima and related to atherosclerosis. Clin J Am Soc Nephrol. 2011;6(2):303–310.
  • Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55(2):648–658.
  • Pecoits-Filho R, Bárány P, Lindholm B, et al. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant. 2002;17(9):1684–1688.
  • Mourad JJ, Girerd X, Boutouyrie P, et al. Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension. 1997;30(6):1425–1430.
  • Powe NR, Jaar B, Furth SL, et al. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int. 1999;55(3):1081–1090.
  • Thompson S, James M, Wiebe N, et al. Cause of death in patients with reduced kidney function. J Am Soc Nephrol. 2015;26(10):2504–2511.
  • Lentine KL, Brennan DC, Schnitzler MA, et al. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol. 2005;16(2):496–506.
  • Chan S, Pascoe EM, Clayton PA, et al. Infection-related mortality in recipients of a kidney transplant in Australia and New Zealand. Clin J Am Soc Nephrol. 2019;14(10):1484–1492.
  • Innocenti GR, Wadei HM, Prieto M, et al. Preemptive living donor kidney transplantation: do the benefits extend to all recipients? Transplantation. 2007;83(2):144–149.
  • Prezelin-Reydit M, Combe C, Harambat J, et al. Prolonged dialysis duration is associated with graft failure and mortality after kidney transplantation: results from the French transplant database. Nephrol Dial Transplant. 2019;34:538–545.
  • Schold JD, Sehgal AR, Srinivas TR, et al. Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes. Am J Transplant. 2010;10(9):2008–2016.
  • Clayton PA, McDonald SP, Russ GR, et al. Long-term outcomes after acute rejection in kidney transplant recipients: an ANZDATA analysis. J Am Soc Nephrol. 2019;30(9):1697–1707.
  • Kaul H, Girndt M, Sester U, et al. Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease. Am J Kidney Dis. 2000;35(4):611–616.
  • Jofre R, López-Gómez JM, Moreno F, et al. Changes in quality of life after renal transplantation. Am J Kidney Dis. 1998;32(1):93–100.
  • Irish GL, Chadban S, McDonald S, et al. Quantifying lead time bias when estimating patient survival in preemptive living kidney donor transplantation. Am J Transplant. 2019;19(12):3367–3376.